VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
WuXi AppTec Co., Ltd. vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
WuXi AppTec Co., Ltd.
603259 · Shanghai Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into WuXi AppTec Co., Ltd.'s moat claims, evidence, and risks.
View 603259 analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: WuXi AppTec Co., Ltd. leads (72 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: WuXi AppTec Co., Ltd. has 3 segments (84% in WuXi Chemistry); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Moat breadth: WuXi AppTec Co., Ltd. has 5 moat types across 3 domains; Amgen Inc. has 5 across 3.
Primary market context
WuXi AppTec Co., Ltd.
WuXi Chemistry
Global synthetic-molecule CRDMO services, including small-molecule discovery, process development, API manufacturing, peptides and oligonucleotides
Global, with major customer exposure to the United States, Europe and China
Large pharmaceutical companies, emerging biotechs and virtual pharma companies
Integrated contract research, development and manufacturing partner across discovery, development and commercial manufacturing
84%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
WuXi AppTec Co., Ltd. strengths
Amgen Inc. strengths
Segment mix
WuXi AppTec Co., Ltd. segments
Full profile >WuXi Chemistry
Competitive
WuXi Testing
Competitive
WuXi Biology
Competitive
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.